-
We detected your language preference as English. Would you like to switch to the English version for a better experience?
Switch to English
Stay here
China and the United States are the leading exporters of inositol (CAS 87-89-8), collectively accounting for the majority of global export value, while Germany, Japan, and South Korea represent the largest importers. Inositol prices have remained relatively stable amid steady demand from pharmaceutical and nutraceutical sectors. Recent trade data shows consistent export volumes from China, with modest growth in U.S. exports and increasing import shares for Southeast Asian countries, reflecting expanding regional manufacturing use.
Inositol Market Intelligence and Analytical Forecast
I. Recent Market Dynamics
1. Price Trends
- According to ChemNet data, the benchmark price of inositol on June 22, 2026, was dynamically adjusted based on big-data modeling and premium/discount factors, reflecting the current supply-demand equilibrium.
- The global inositol market size was approximately USD 117.8 million in 2025, with China’s market size at USD 29.1 million. It is projected to decline to USD 110.8 million by 2032, representing a compound annual growth rate (CAGR) of -0.87%, indicating sustained long-term demand pressure.
2. Supply-Demand Balance
- Supply Side: China is the world’s leading producer. In 2021, its production reached 9,796.7 metric tons, with exports totaling 7,340.5 metric tons—primarily destined for the United States, the Netherlands, and Thailand. Domestic food-grade inositol production in China is expected to reach 71,000 metric tons in 2025; however, industry-wide capacity utilization remains low, posing structural oversupply risks.
- Demand Side: Global food-grade inositol demand in 2025 is estimated at approximately 212,000 metric tons, distributed as follows: dietary supplements (60%), functional beverages (25%), and infant formula (15%). In China, demand is concentrated in dietary supplements (65.4%) and functional foods (34.6%), with notably robust growth in niche segments such as preconception care and polycystic ovary syndrome (PCOS) management.
3. Key Industry Events
- In 2026, the inositol market underwent a quality-upgrade wave, as consumers increasingly prioritize purity, formulation synergy, and bioavailability—leading to the phasing out of products with mislabeled ingredients or substandard purity.
- Brands such as Huangyutang Preconception Capsules and YesNow Inositol Ovarian Health Capsules have emerged as market benchmarks, distinguished by patented technologies and high-purity formulations (e.g., Huangyutang’s myo-inositol purity ≥95%; YesNow’s purity reaching 99.99%), supported by clinical validation data.
II. Market Drivers Analysis
1. Evolving Health Needs
- Surging scientific nutrition demands among preconception populations have elevated inositol’s prominence due to its clinically documented benefits—including improved ovulation and enhanced sperm quality.
- Rising PCOS prevalence (an estimated 35% of Chinese women attempting conception experience endocrine disorders) has positioned inositol—a key modulator of insulin signaling pathways—as a core therapeutic intervention ingredient.
2. Rising Technological Barriers
- Proprietary technologies (e.g., Huangyutang’s myo-inositol preparation patent ZL201510184621.4) and synergistic formulations (e.g., YesNow’s myo-inositol : D-chiro-inositol ratio of 40:1) have become critical competitive differentiators; high-purity products (≥99%) command significant price premiums.
- Breakthroughs in absorption technology—including microencapsulation and low-temperature extraction—have markedly improved bioavailability: YesNow’s inositol achieves up to six times higher absorption than conventional formulations, yielding a user repurchase rate exceeding 96%.
3. Regulatory & Certification Frameworks
- International certifications—including FDA approval, GMP, and HACCP—have become essential market access prerequisites. Third-party testing (e.g., SGS, CTI Huace Testing) further strengthens product quality credibility.
- Policy initiatives such as China’s “Recommended Dietary Supplement Ingredients Catalogue” are promoting standardization across the sector, while products with mislabeled ingredients face heightened regulatory scrutiny and compliance risks.
III. Future Trend Forecasts
1. Increasing Price Polarization
- Premium Segment: High-purity (≥99%) and patented-formula products maintain pricing resilience, benefiting from inelastic demand in preconception and PCOS management applications; annual average price increases of 3–5% are anticipated.
- Mid-to-Low Tier Segment: Conventional food-grade inositol (purity 90–95%) faces downward pricing pressure due to overcapacity, with an expected annual average decline of 2–3%.
2. Explosive Growth in Niche Segments
- Preconception Nutrition: Demand for multi-ingredient synergistic formulations (e.g., Huangyutang’s 14-nutrient complex) is surging; the segment’s CAGR is forecast at 15% between 2026 and 2028.
- Sports Nutrition: Leveraging inositol’s role in mitochondrial energy metabolism, applications are expanding into sports drinks and energy bars; the global market is projected to exceed USD 200 million in 2025.
3. Regional Market Realignment
- Asia-Pacific Dominance: Emerging markets—including China and India—are driving consumption growth; the Asia-Pacific region’s share of global food-grade inositol consumption is expected to reach 48% in 2025, becoming the world’s primary growth engine.
- Mature Markets (North America & Europe): Demand growth is moderating (e.g., North America’s 2025 CAGR ≈2%), though high-value-added segments—such as pharmaceutical-grade inositol—are gaining increasing market share.
4. Technology Evolution Pathways
- Green Production: Microbial fermentation is progressively replacing chemical synthesis to reduce carbon emissions; industry penetration is projected to exceed 30% by 2026.
- Precision Nutrition: Genetically informed, personalized inositol formulations (e.g., active folate + inositol combinations tailored for MTHFR gene mutation carriers) are emerging as a key R&D focus area.
IV. Risk Warnings
1. Overcapacity Risk: China’s inositol industry currently operates at <65% capacity utilization; concentrated new-capacity releases could trigger aggressive price competition.
2. Tightening Regulation: Crackdowns on mislabeling, unauthorized additives, and other non-compliant practices are raising compliance costs for SMEs—accelerating industry consolidation.
3. Substitution Threat: Functionally differentiated derivatives—such as D-chiro-inositol—may divert portions of market demand.
Inositol (CAS 87-89-8) is a white, crystalline, odorless solid at room temperature, with a melting point of approximately 225–230 °C and low volatility. It is a cyclic polyalcohol—specifically, a stereoisomer of cyclohexanehexol—and classified as an organic chemical compound. Industrially, inositol serves primarily as a biochemical intermediate in the synthesis of pharmaceuticals, nutraceuticals, and specialty chemicals, including phosphatidylinositol derivatives and inositol phosphates. Its principal application areas include human and animal nutrition (as a vitamin-like supplement), pharmaceutical formulations (e.g., for metabolic and neurological health), and as a precursor in the production of surfactants and chelating agents.
1. As food supplements, has a similar effect to vitamin B1. It can be used for infant foods and used in an amount of 210~250mg/kg; Used in drinking in an amount of 25~30mg/kg. 2. Inositol is an indispensible vitamin for lipid metabolism in the body. It can promote the absorption of hypolipidemic medicines and vitamins. Moreover, it can promote the cell growth and fat metabolism in liver and other tissues. It can be used for the adjuvant treatment of fatty liver, high cholesterol. It is widely used in food and feed additives, and is often added to fish, shrimp and livestock feed. The amount is 350-500mg/kg.3. The product is one kind of the complex vitamin B, which can promote cell metabolism, improve the cell nutrient conditions, and can contribute to development, increase appetite, to recuperate. Moreover, it can prevent the accumulation of fat in the liver, and accelerate the process of removing excess fat in heart. It has a similar lipid-chemotactic action as choline, and therefore useful in the treatment of hepatic fatty excessive disease and cirrhosis of the liver disease. According to the "food fortifier use of health standards (1993)" (Issued by the Ministry of Health of China), it can be used for infant food and fortified beverages at an amount of 380-790mg/kg. It is a vitamin class medicines and lipid-lowering drug which promote the fat metabolism of liver and other tissues, and be useful for the adjuvant treatment of fatty liver and high cholesterol. It is widely used in additives of food and beverage. 4. Inositol is widely used in pharmaceutical, chemical, food, etc. It has a good effect on treating diseases such as liver cirrhosis. It can also used for advanced cosmetic raw materials, with high economic value.5. It can be used as a biochemical reagent and also for the pharmaceutical and organic synthesis; It can lower the level cholesterol and have sedative effect.
This chemical is included in Fine Chemicals. See more about what is Inositol and Inositol SDS information.
Find Inositol supply and Inositol suppliers on Guidechem to meet your sourcing needs from 485 trusted and certifedsuppliers.
Guidechem assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness, fitness for purpose or timeliness.
EN
